Notice of Meeting, 9526-9527 [2021-03065]

Download as PDF 9526 Federal Register / Vol. 86, No. 29 / Tuesday, February 16, 2021 / Notices ESTIMATED ANNUALIZED BURDEN HOURS—Continued Total annual burden hours Study Closure or Transfer of Study Review Responsibility (Attachment B43). Unanticipated Problem or Serious or Continuing Noncompliance Reporting Form (Attachment B44). Change of Signatory Institution PI Form (Attachment B45). Request Waiver of Assent Form (Attachment B46). CIRB Waiver of Consent Request Supplemental Form (Attachment B47). Review Worksheet CIRB Review for Inclusion of Incarcerated Participants (Attachment B48). Notification of Incarcerated Participant Form (B49). CTSU OPEN Survey (Attachment C03) ............... CIRB Customer Satisfaction Survey (Attachment C04). Follow-up Survey (Communication Audit) (Attachment C05). CIRB Board Member Annual Assessment Survey (Attachment C07). PIO Customer Satisfaction Survey (Attachment C08). Audit Scheduling Form (Attachment D01) ............ Preliminary Audit Finding Form (Attachment D02) Audit Maintenance Form (Attachment D03) ......... Final Audit finding Report Form (Attachment D04). Follow-up Form (Attachment D05) ....................... Roster Maintenance Form (Attachment D06) ...... Final Report and CAPA Request Form (Attachment D07). NCI/DCTD/CTEP FDA Form 1572 for Annual Submission (Attachment E01). NCI/DCTD/CTE Biosketch (Attachment E02) ...... Health Care Practitioner 1,680 1 15/60 420 Health Care Practitioner 360 1 20/60 120 Health Care Practitioner 120 1 20/60 40 Health Care Practitioner 35 1 20/60 12 Health Care Practitioner 20 1 15/60 5 Board Members ............ 20 1 60/60 20 Health Care Practitioner 20 1 20/60 7 Health Care Practitioner Participants ................... 10 600 1 1 15/60 15/60 3 150 Participants/Board Members. Board Members ............ 300 1 15/60 75 60 1 15/60 15 Health Care Practitioner 60 1 5/60 5 Practitioner Practitioner Practitioner Practitioner 152 152 152 75 5 5 5 11 21/60 10/60 9/60 1,098/60 266 127 114 15,098 Health Care Practitioner Health Care Practitioner Health Care Practitioner 75 5 12 7 1 9 27/60 18/60 1,800/60 236 2 3,240 Physician ...................... 26,500 1 15/60 6,625 Physician; Health Care Practitioner. Physician; Health Care Practitioner. Physician ...................... 48,000 1 120/60 96,000 48,000 1 15/60 12,000 24,000 1 10/60 4,000 ....................................... 167,715 235,670 ........................ 151,792 NCI/DCTD/CTEP Financial Disclosure Form (Attachment E03). NCI/DCTD/CTEP Agent Shipment Form (ASF) (Attachment E04). Totals ............................................................. Dated: February 1, 2021. Diane Kreinbrink, Project Clearance Liaison, National Cancer Institute, National Institutes of Health. [FR Doc. 2021–03046 Filed 2–12–21; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration khammond on DSKJM1Z7X2PROD with NOTICES Average burden per response (in hours) Type of respondent Notice of Meeting Pursuant to Public Law 92–463, notice is hereby given that the Substance Abuse and Mental Health Services Administration’s (SAMHSA) Center for Substance Abuse Prevention’s (CSAP) Drug Testing Advisory Board VerDate Sep<11>2014 17:04 Feb 12, 2021 Jkt 253001 Health Health Health Health Care Care Care Care Number of respondents Number of responses per respondent Form name (DTAB) will convene via web conference on March 2nd, 2021, from 10:00 a.m. EST to 4:30 p.m. EST, and March 3rd, 2021, from 10:00 a.m. EST to 4:30 p.m. EST. The board will meet in open-session March 2nd, 2021, from 10:00 a.m. EST to 2:00 p.m. EST to discuss the Mandatory Guidelines for Federal Workplace Drug Testing Programs with updates from the Department of Transportation, the Nuclear Regulatory Commission, and the Department of Defense. Other discussion topics include an update on marijuana studies and efforts as well as the Employee Assistance Program (EAP) Toolkit. The board will meet in closed-session on March 2nd, 2021, from 2:15 p.m. EST to 4:30 p.m. EST, and March 3rd, 2021, from 10:00 a.m. EST to 4:30 p.m. EST, PO 00000 Frm 00050 Fmt 4703 Sfmt 4703 to discuss confidential issues surrounding the proposed Mandatory Guidelines for Federal Workplace Drug Testing Programs (hair), the Federal Drug-Free Workplace Programs and emerging issues, updates on the revisions of the Urine and Oral Fluid Mandatory Guidelines and the Biomarker Table, preliminary and unpublished studies from the Johns Hopkins University Behavioral Pharmacology Research Unit (BPRU), and cannabidiol (CBD) information from FDA. Therefore, the March 2nd, 2021, from 2:15 p.m. EST to 4:30 p.m. EST, and the March 3rd, 2021, from 10:00 a.m. EST to 4:30 p.m. EST, meetings are closed to the public, as determined by the Assistant Secretary for Mental Health and Substance Use, SAMHSA, in accordance with 5 U.S.C. 552b(c)(4) and E:\FR\FM\16FEN1.SGM 16FEN1 Federal Register / Vol. 86, No. 29 / Tuesday, February 16, 2021 / Notices (9)(B), and 5 U.S.C. App. 2, Section 10(d). Meeting registration can be completed at http://snacregister.samhsa.gov/ MeetingList.aspx. Web conference and call information will be sent after completing registration. Meeting information and a roster of DTAB members may be obtained by accessing the SAMHSA Advisory Committees website, https://www.samhsa.gov/ about-us/advisory-councils/meetings or by contacting the Designated Federal Officer, Jennifer Fan. Committee Name: Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Prevention, Drug Testing Advisory Board. Dates/Time/Type: March 2, 2021, from 10:00 a.m. to 2:00 p.m. EST: OPEN, March 2, 2021, from 2:15 p.m. to 4:30 p.m. EST: CLOSED, March 3, 2021, from 10:00 a.m. to 4:30 p.m. EST: CLOSED. Place: Substance Abuse and Mental Health Services Administration, 5600 Fishers Lane, Rockville, MD 20857. Contact: Jennifer Fan, Senior Pharmacist, Center for Substance Abuse Prevention, 5600 Fishers Lane, Room 16N06D, Rockville, Maryland 20857, Telephone: (240) 276–1759, Email: jennifer.fan@samhsa.hhs.gov. Note: For technical reasons, SAMHSA was unable to provide the normal 15-day advance noticification of the meeting. Anastasia Marie Donovan, Policy Anayst. [FR Doc. 2021–03065 Filed 2–12–21; 8:45 am] BILLING CODE 4162–20–P DEPARTMENT OF HOMELAND SECURITY U.S. Customs and Border Protection [1651–0136] Generic Clearance for the Collection of Qualitative Feedback on Agency Service Delivery U.S. Customs and Border Protection (CBP), Department of Homeland Security. ACTION: 30-Day notice and request for comments; extension of an existing collection of information. khammond on DSKJM1Z7X2PROD with NOTICES AGENCY: The Department of Homeland Security, U.S. Customs and Border Protection will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995 (PRA). The SUMMARY: VerDate Sep<11>2014 17:04 Feb 12, 2021 Jkt 253001 information collection is published in the Federal Register to obtain comments from the public and affected agencies. DATES: Comments are encouraged and must be submitted (no later than March 18, 2021 to be assured of consideration. ADDRESSES: Written comments and/or suggestions regarding the item(s) contained in this notice should be sent within 30 days of publication of this notice to www.reginfo.gov/public/do/ PRAMain. Find this particular information collection by selecting ‘‘Currently under 30-day Review—Open for Public Comments’’ or by using the search function. FOR FURTHER INFORMATION CONTACT: Requests for additional PRA information should be directed to Seth Renkema, Chief, Economic Impact Analysis Branch, U.S. Customs and Border Protection, Office of Trade, Regulations and Rulings, 90 K Street NE, 10th Floor, Washington, DC 20229–1177, Telephone number 202–325–0056 or via email CBP_PRA@cbp.dhs.gov. Please note that the contact information provided here is solely for questions regarding this notice. Individuals seeking information about other CBP programs should contact the CBP National Customer Service Center at 877–227–5511, (TTY) 1–800–877–8339, or CBP website at https://www.cbp.gov/. SUPPLEMENTARY INFORMATION: CBP invites the general public and other Federal agencies to comment on the proposed and/or continuing information collections pursuant to the Paperwork Reduction Act of 1995 (44 U.S.C. 3501 et seq.). This proposed information collection was previously published in the Federal Register (85 FR 75347) on November 25, 2020, allowing for a 60day comment period. This notice allows for an additional 30 days for public comments. This process is conducted in accordance with 5 CFR 1320.8. Written comments and suggestions from the public and affected agencies should address one or more of the following four points: (1) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (2) the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (3) suggestions to enhance the quality, utility, and clarity of the information to be collected; and (4) suggestions to minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, PO 00000 Frm 00051 Fmt 4703 Sfmt 4703 9527 mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. The comments that are submitted will be summarized and included in the request for approval. All comments will become a matter of public record. Overview of This Information Collection Title: Generic Clearance for the Collection of Qualitative Feedback on Agency Service Delivery. OMB Number: 1651–0136. Current Actions: This submission is being made to extend the expiration date with no change to the burden hours. Type of Review: Extension (without change). Affected Public: Individuals and businesses. Abstract: Executive Order 12862 directs Federal agencies to provide service to the public that matches or exceeds the best service available in the private sector. In order to work continuously to ensure that our programs are effective and meet our customers’ needs, U.S. Customs and Border Protection (CBP) (hereafter ‘‘the Agency’’) seeks to obtain OMB approval of a generic clearance to collect qualitative feedback on our service delivery. By qualitative feedback we mean information that provides useful insights on perceptions and opinions, but are not statistical surveys that yield quantitative results that can be generalized to the population of study. This collection of information is necessary to enable CBP to garner customer and stakeholder feedback in an efficient, timely manner, in accordance with our commitment to improving service delivery. The information collected from our customers and stakeholders will help ensure that users have an effective, efficient, and satisfying experience with CBP’s programs. This feedback will provide insights into customer or stakeholder perceptions, experiences and expectations, provide an early warning of issues with service, or focus attention on areas where communication, training or changes in operations might improve delivery of products or services. These collections will allow for ongoing, collaborative and actionable communications between CBP and its customers and stakeholders. It will also allow feedback to contribute directly to the improvement of program management. Type of Information Collection: Comment Cards. E:\FR\FM\16FEN1.SGM 16FEN1

Agencies

[Federal Register Volume 86, Number 29 (Tuesday, February 16, 2021)]
[Notices]
[Pages 9526-9527]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-03065]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Notice of Meeting

    Pursuant to Public Law 92-463, notice is hereby given that the 
Substance Abuse and Mental Health Services Administration's (SAMHSA) 
Center for Substance Abuse Prevention's (CSAP) Drug Testing Advisory 
Board (DTAB) will convene via web conference on March 2nd, 2021, from 
10:00 a.m. EST to 4:30 p.m. EST, and March 3rd, 2021, from 10:00 a.m. 
EST to 4:30 p.m. EST.
    The board will meet in open-session March 2nd, 2021, from 10:00 
a.m. EST to 2:00 p.m. EST to discuss the Mandatory Guidelines for 
Federal Workplace Drug Testing Programs with updates from the 
Department of Transportation, the Nuclear Regulatory Commission, and 
the Department of Defense. Other discussion topics include an update on 
marijuana studies and efforts as well as the Employee Assistance 
Program (EAP) Toolkit. The board will meet in closed-session on March 
2nd, 2021, from 2:15 p.m. EST to 4:30 p.m. EST, and March 3rd, 2021, 
from 10:00 a.m. EST to 4:30 p.m. EST, to discuss confidential issues 
surrounding the proposed Mandatory Guidelines for Federal Workplace 
Drug Testing Programs (hair), the Federal Drug-Free Workplace Programs 
and emerging issues, updates on the revisions of the Urine and Oral 
Fluid Mandatory Guidelines and the Biomarker Table, preliminary and 
unpublished studies from the Johns Hopkins University Behavioral 
Pharmacology Research Unit (BPRU), and cannabidiol (CBD) information 
from FDA. Therefore, the March 2nd, 2021, from 2:15 p.m. EST to 4:30 
p.m. EST, and the March 3rd, 2021, from 10:00 a.m. EST to 4:30 p.m. 
EST, meetings are closed to the public, as determined by the Assistant 
Secretary for Mental Health and Substance Use, SAMHSA, in accordance 
with 5 U.S.C. 552b(c)(4) and

[[Page 9527]]

(9)(B), and 5 U.S.C. App. 2, Section 10(d).
    Meeting registration can be completed at http://snacregister.samhsa.gov/MeetingList.aspx. Web conference and call 
information will be sent after completing registration. Meeting 
information and a roster of DTAB members may be obtained by accessing 
the SAMHSA Advisory Committees website, https://www.samhsa.gov/about-us/advisory-councils/meetings or by contacting the Designated Federal 
Officer, Jennifer Fan.
    Committee Name: Substance Abuse and Mental Health Services 
Administration, Center for Substance Abuse Prevention, Drug Testing 
Advisory Board.
    Dates/Time/Type: March 2, 2021, from 10:00 a.m. to 2:00 p.m. EST: 
OPEN, March 2, 2021, from 2:15 p.m. to 4:30 p.m. EST: CLOSED, March 3, 
2021, from 10:00 a.m. to 4:30 p.m. EST: CLOSED.
    Place: Substance Abuse and Mental Health Services Administration, 
5600 Fishers Lane, Rockville, MD 20857.
    Contact: Jennifer Fan, Senior Pharmacist, Center for Substance 
Abuse Prevention, 5600 Fishers Lane, Room 16N06D, Rockville, Maryland 
20857, Telephone: (240) 276-1759, Email: [email protected].

    Note:  For technical reasons, SAMHSA was unable to provide the 
normal 15-day advance noticification of the meeting.


Anastasia Marie Donovan,
Policy Anayst.
[FR Doc. 2021-03065 Filed 2-12-21; 8:45 am]
BILLING CODE 4162-20-P